Management of the Adnexal Mass: Considerations for the Family Medicine Physician
Ovarian cancer is the most deadly gynecological cancer, so proper assessment of a pelvic mass is necessary in order to determine which are at high risk for malignancy and should be referred to a gynecologic oncologist. However, in a family medicine setting, evaluation and treatment of these masses c...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-07-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.913549/full |
| _version_ | 1818536700776808448 |
|---|---|
| author | Brian Bullock Lisa Larkin Lisa Larkin Lisa Larkin Lauren Turker Kate Stampler |
| author_facet | Brian Bullock Lisa Larkin Lisa Larkin Lisa Larkin Lauren Turker Kate Stampler |
| author_sort | Brian Bullock |
| collection | DOAJ |
| description | Ovarian cancer is the most deadly gynecological cancer, so proper assessment of a pelvic mass is necessary in order to determine which are at high risk for malignancy and should be referred to a gynecologic oncologist. However, in a family medicine setting, evaluation and treatment of these masses can be challenging due to a lack of resources. A number of risk assessment tools are available to family medicine physicians, including imaging techniques, imaging systems, and blood-based biomarker assays each with their respective pros and cons, and varying ability to detect malignancy in pelvic masses. Effective utilization of these assessment tools can inform the care pathway for patients which present with an adnexal mass, such as expectant management for those with a low risk of malignancy, or referral to a gynecologic oncologist for surgery and staging, for those at high risk of malignancy. Triaging patients to the appropriate care pathway improves patient outcomes and satisfaction, and family medicine physicians can play a key role in this decision-making process. |
| first_indexed | 2024-12-11T18:41:19Z |
| format | Article |
| id | doaj.art-1125eedca75d46919c3daa65a64585ef |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-12-11T18:41:19Z |
| publishDate | 2022-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-1125eedca75d46919c3daa65a64585ef2022-12-22T00:54:36ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-07-01910.3389/fmed.2022.913549913549Management of the Adnexal Mass: Considerations for the Family Medicine PhysicianBrian Bullock0Lisa Larkin1Lisa Larkin2Lisa Larkin3Lauren Turker4Kate Stampler5Main Line Health, Philadelphia, PA, United StatesLisa Larkin, MD, and Associates, Cincinnati, OH, United StatesMs. Medicine Healthcare Organization, Cincinnati, OH, United StatesCincinnati Sexual Health Consortium, Cincinnati, OH, United StatesMain Line Health, Philadelphia, PA, United StatesEinstein Healthcare Network, Philadelphia, PA, United StatesOvarian cancer is the most deadly gynecological cancer, so proper assessment of a pelvic mass is necessary in order to determine which are at high risk for malignancy and should be referred to a gynecologic oncologist. However, in a family medicine setting, evaluation and treatment of these masses can be challenging due to a lack of resources. A number of risk assessment tools are available to family medicine physicians, including imaging techniques, imaging systems, and blood-based biomarker assays each with their respective pros and cons, and varying ability to detect malignancy in pelvic masses. Effective utilization of these assessment tools can inform the care pathway for patients which present with an adnexal mass, such as expectant management for those with a low risk of malignancy, or referral to a gynecologic oncologist for surgery and staging, for those at high risk of malignancy. Triaging patients to the appropriate care pathway improves patient outcomes and satisfaction, and family medicine physicians can play a key role in this decision-making process.https://www.frontiersin.org/articles/10.3389/fmed.2022.913549/fullmultivariate index assaybiomarkersultrasoundsimple rulespelvic massovarian cancer |
| spellingShingle | Brian Bullock Lisa Larkin Lisa Larkin Lisa Larkin Lauren Turker Kate Stampler Management of the Adnexal Mass: Considerations for the Family Medicine Physician Frontiers in Medicine multivariate index assay biomarkers ultrasound simple rules pelvic mass ovarian cancer |
| title | Management of the Adnexal Mass: Considerations for the Family Medicine Physician |
| title_full | Management of the Adnexal Mass: Considerations for the Family Medicine Physician |
| title_fullStr | Management of the Adnexal Mass: Considerations for the Family Medicine Physician |
| title_full_unstemmed | Management of the Adnexal Mass: Considerations for the Family Medicine Physician |
| title_short | Management of the Adnexal Mass: Considerations for the Family Medicine Physician |
| title_sort | management of the adnexal mass considerations for the family medicine physician |
| topic | multivariate index assay biomarkers ultrasound simple rules pelvic mass ovarian cancer |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2022.913549/full |
| work_keys_str_mv | AT brianbullock managementoftheadnexalmassconsiderationsforthefamilymedicinephysician AT lisalarkin managementoftheadnexalmassconsiderationsforthefamilymedicinephysician AT lisalarkin managementoftheadnexalmassconsiderationsforthefamilymedicinephysician AT lisalarkin managementoftheadnexalmassconsiderationsforthefamilymedicinephysician AT laurenturker managementoftheadnexalmassconsiderationsforthefamilymedicinephysician AT katestampler managementoftheadnexalmassconsiderationsforthefamilymedicinephysician |